Catalyst Pharmaceuticals(CPRX) - 2024 Q2 - Quarterly Report
Catalyst Pharmaceuticals(CPRX)2024-08-07 20:05Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [Mark One] ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2024 OR ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 001-33057 | --- | --- | |--------------------------------------------------------------------------------------------|---------------------------------------- ...